651. Transdermal rotigotine patch in Parkinson's disease with a history of intestinal operation.
- Author
-
Ogawa T, Oyama G, and Hattori N
- Subjects
- Adult, Dopamine Agonists therapeutic use, Dose-Response Relationship, Drug, Humans, Intestine, Small surgery, Malabsorption Syndromes etiology, Male, Tetrahydronaphthalenes therapeutic use, Thiophenes therapeutic use, Transdermal Patch, Treatment Outcome, Dopamine Agonists administration & dosage, Parkinson Disease drug therapy, Tetrahydronaphthalenes administration & dosage, Thiophenes administration & dosage
- Abstract
A 42-year-old Japanese man with a history of small intestine resection and familial Mediterranean fever was referred to our hospital for a second opinion on parkinsonism. At the age of 35, the patient attended a hospital due to impaired left-hand movement and resting tremor. He was previously diagnosed with multiple system atrophy based on the lack of effectiveness of levodopa treatment. With suspicion of malabsorption due to his history of ileostomy, a levodopa challenge test with levodopa intravenous infusion was conducted, and revealed a 65% improvement in Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale part III. Therefore, diagnosis of Parkinson's disease was made and a transdermal rotigotine patch was selected as a treatment. This treatment dose-dependently improved the patient's symptoms. The transdermal drug delivery should be considered when patients show dose failure due to malabsorption., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Published
- 2018
- Full Text
- View/download PDF